Latest News
Thursday, September 3, 2026
World
Trump Threatens More Strikes as Hormuz Conflict Deepens Amid Escalating US-Iran Tensions
Tensions between the US and Iran have escalated, with both sides reportedly launching strikes, including a US strike on Iran's southern coast and Iranian retaliation against US bases in the Middle East. This renewed conflict over the Strait of Hormuz has raised global concerns, prompting the US to warn other countries against supporting Tehran.
Tech
Uber and Wayve Launch First-Ever Supervised Autonomous Ride-Hailing Service in the UK
Uber and Wayve have introduced supervised autonomous ride-hailing in London, marking the UK's debut of such a service. Londoners can now request an UberX, Uber Electric, or Uber Comfort and potentially be matched with an all-electric Ford Mustang Mach-E, featuring Wayve's AI Driver, with a trained safety driver onboard.
Business
The AI Cloud Math is Broken, Creating a Power Shift Within Big Tech
The economics of AI cloud computing are undergoing a significant shift, making it increasingly cost-effective for companies to purchase AI hardware outright rather than relying on cloud rental services. This change is driven by the rising cost of AI hardware and a slower decrease in cloud rental prices, potentially altering the profit landscape for major tech firms.
Science
New Qubit Architecture Developed at MIT Enables Faster, More Accurate Quantum Operations
MIT researchers have unveiled an innovative "arm qubit" architecture designed to enhance quantum computing. This new design features distinct components for data storage and interaction, allowing qubits to communicate more rapidly while maintaining stability, a crucial step towards building practical, fault-tolerant quantum computers.
Unexpected Discovery Reveals Potential Drug Target in Childhood Brain Tumors
Scientists at Lund University have made an unexpected breakthrough, identifying a potential drug target for medulloblastoma, a common malignant childhood brain tumor. Their research, stemming from studies on a blood stem cell multiplying molecule, offers new insights into tumor development and suggests avenues for future treatments, including drug repurposing.









